Full text is available at the source.
Abstract
Obesity in older adults (≥65 years) is associated with multiple health issues.
- Obesity may lead to osteoarthritis and impaired mobility in older adults.
- Reduced quality of life and cardiovascular disease are commonly linked to obesity in this age group.
- Glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy could provide benefits for older adults dealing with obesity.
- The review highlights both potential benefits and risks of GLP-1 RA therapy in older individuals.
Simplified